Therefore, the results obtained both in vitro and in vivo confirm the important role of PPARγ in mediating the neuroprotective actions of CBD in experimental models of Alzheimer’s disease [17]. This evidence concerns the gene PPARG and early-onset autosomal dominant Alzheimer disease.